Published in Stem Cell Res Ther on May 04, 2010
Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther (2010) 1.00
Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med (2015) 0.94
Human Umbilical Cord-Derived Mesenchymal Stem Cells Utilize Activin-A to Suppress Interferon-γ Production by Natural Killer Cells. Front Immunol (2014) 0.85
Differentiation and regeneration potential of mesenchymal progenitor cells derived from traumatized muscle tissue. J Cell Mol Med (2011) 0.84
Characterization of bursa subacromialis-derived mesenchymal stem cells. Stem Cell Res Ther (2015) 0.79
Targeting Fas in osteoresorptive disorders. Expert Opin Ther Targets (2010) 0.79
Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair. Front Genet (2016) 0.77
Myogenic differentiation potential of human tonsil-derived mesenchymal stem cells and their potential for use to promote skeletal muscle regeneration. Int J Mol Med (2016) 0.77
Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy. Front Physiol (2016) 0.76
Serial changes in the proliferation and differentiation of adipose-derived stem cells after ionizing radiation. Stem Cell Res Ther (2016) 0.75
Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton's jelly mesenchymal stem cells. Stem Cell Res Ther (2016) 0.75
Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. PLoS Genet (2016) 0.75
Tonsil-Derived Mesenchymal Stem Cells Differentiate into a Schwann Cell Phenotype and Promote Peripheral Nerve Regeneration. Int J Mol Sci (2016) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A (2000) 11.41
How is pluripotency determined and maintained? Development (2007) 6.92
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol (2007) 6.69
TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development (2005) 5.66
Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol (2004) 5.43
Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum (2001) 4.57
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood (2003) 4.43
Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood (2005) 4.10
Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood (2003) 4.09
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood (2004) 4.04
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (2007) 3.97
All for one and one for all: condensations and the initiation of skeletal development. Bioessays (2000) 3.40
Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells (2005) 3.03
Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells (2007) 2.54
Activin-binding protein from rat ovary is follistatin. Science (1990) 2.38
Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem Cells (2006) 2.37
Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res (2002) 2.18
Isolation of multipotent cells from human term placenta. Stem Cells (2005) 2.03
Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J Bone Miner Res (2003) 1.94
Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol (2002) 1.90
Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells (2007) 1.89
Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology (2002) 1.61
Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res (1990) 1.55
In vitro characterization of human dental pulp cells: various isolation methods and culturing environments. Cell Tissue Res (2006) 1.48
Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem Biophys Res Commun (1987) 1.43
Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue. Stem Cells (2005) 1.39
Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther (2005) 1.37
Stem cells in the periodontal ligament. Oral Dis (2006) 1.36
The activin A-follistatin system: potent regulator of human extracellular matrix mineralization. FASEB J (2007) 1.31
Modulation of immune responses by mesenchymal stem cells. Ann N Y Acad Sci (2007) 1.30
Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am (2008) 1.28
Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) (2002) 1.26
Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol (2003) 1.25
Mesenchymal progenitor cells derived from traumatized human muscle. J Tissue Eng Regen Med (2009) 1.20
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage (2007) 1.19
Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs (2002) 1.12
Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem (1993) 1.09
Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood (2007) 1.06
The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res (2000) 1.02
Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum (2003) 1.01
Inhibitory effects of activin-A on osteoblast differentiation during cultures of fetal rat calvarial cells. J Cell Biochem (1999) 0.99
Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. J Biol Chem (1992) 0.99
Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin Exp Immunol (1998) 0.97
Activin enhances chondrogenesis of limb bud cells: stimulation of precartilaginous mesenchymal condensations and expression of NCAM. Dev Biol (1993) 0.96
Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem (1992) 0.95
Human palatine tonsil: a new potential tissue source of multipotent mesenchymal progenitor cells. Arthritis Res Ther (2008) 0.94
Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab Invest (1997) 0.94
Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases. Curr Neuropharmacol (2005) 0.92
Effects of activin A on proliferation and differentiation of human lung fibroblasts. Biochem Biophys Res Commun (1996) 0.91
Local administration of activin promotes fracture healing in the rat fibula fracture model. Bone (1999) 0.91
Production of activin A and its roles in inflammation and hematopoiesis. Cytokines Cell Mol Ther (1997) 0.90
Follistatin rescues the inhibitory effect of activin A on the differentiation of bovine preadipocyte. Domest Anim Endocrinol (2006) 0.88
Isolation and phenotypical characterization of mesenchymal stem cells from human fetal thymus. Bull Exp Biol Med (2005) 0.88
Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology (1991) 0.87
Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells. J Leukoc Biol (2002) 0.84
Rat follistatin: gonadal and extragonadal expression and evidence for alternative splicing. Biochem Biophys Res Commun (1990) 0.84
Detection of functional and dimeric activin A in human marrow microenvironment. Implications for the modulation of erythropoiesis. Ann N Y Acad Sci (1994) 0.82
Changes in extracellular activin A:follistatin ratio during differentiation of a mesenchymal progenitor cell line, ROB-C26 into osteoblasts and adipocytes. Life Sci (2007) 0.82
Activin A increases the bone mass of grafted bone in C3H/HeJ mice. Calcif Tissue Int (2002) 0.82
Activin A induces craniofacial cartilage from undifferentiated Xenopus ectoderm in vitro. Proc Natl Acad Sci U S A (2002) 0.76
Electrospun nanofibrous structure: a novel scaffold for tissue engineering. J Biomed Mater Res (2002) 4.71
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther (2007) 3.97
Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells (2007) 3.79
Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95
Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem (2004) 2.71
Comparison of minimally invasive direct anterior versus posterior total hip arthroplasty based on inflammation and muscle damage markers. J Bone Joint Surg Am (2011) 2.37
Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J (2004) 2.30
Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem (2003) 2.25
Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res (2002) 2.18
Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials (2005) 2.18
Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater (2006) 2.14
Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A (2003) 2.07
Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A (2010) 2.06
Sirt1-deficient mice exhibit an altered cartilage phenotype. Joint Bone Spine (2013) 2.06
Transient exposure to transforming growth factor beta 3 under serum-free conditions enhances the biomechanical and biochemical maturation of tissue-engineered cartilage. Tissue Eng Part A (2008) 1.95
Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Mol Biotechnol (2002) 1.90
Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells (2014) 1.89
Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng Part B Rev (2009) 1.88
Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage (2004) 1.87
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum (2008) 1.83
Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells (2003) 1.82
Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells (2006) 1.78
MicroRNAs and cell differentiation in mammalian development. Birth Defects Res C Embryo Today (2006) 1.78
Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther (2008) 1.75
iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin. Stem Cells Dev (2010) 1.73
Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol (2010) 1.68
Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol (2008) 1.67
Technology Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol (2006) 1.66
Mechanoactive tenogenic differentiation of human mesenchymal stem cells. Tissue Eng Part A (2008) 1.63
Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol (2006) 1.59
Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size. Tissue Eng (2006) 1.54
Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem (2007) 1.52
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther (2012) 1.48
Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem (2009) 1.47
Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol (2007) 1.46
Transient exposure to transforming growth factor beta 3 improves the mechanical properties of mesenchymal stem cell-laden cartilage constructs in a density-dependent manner. Tissue Eng Part A (2009) 1.43
Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng (2004) 1.34
Stem/progenitor cells from inflamed human dental pulp retain tissue regeneration potential. Regen Med (2010) 1.32
Regional multilineage differentiation potential of meniscal fibrochondrocytes: implications for meniscus repair. Anat Rec (Hoboken) (2007) 1.30
Distinct functions of BMP4 and GDF5 in the regulation of chondrogenesis. J Cell Biochem (2004) 1.30
Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am (2008) 1.28
Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials (2012) 1.28
Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. J Biol Chem (2007) 1.27
Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev Dyn (2002) 1.27
Glucocorticoids promote chondrogenic differentiation of adult human mesenchymal stem cells by enhancing expression of cartilage extracellular matrix genes. Stem Cells (2006) 1.26
Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem (2002) 1.25
Detection of periprosthetic infections with use of ribosomal RNA-based polymerase chain reaction. J Bone Joint Surg Am (2010) 1.23
Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev (2010) 1.22
Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol (2008) 1.22
Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res (2009) 1.22
Hypertrophy in mesenchymal stem cell chondrogenesis: effect of TGF-beta isoforms and chondrogenic conditioning. Cells Tissues Organs (2010) 1.21
Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A (2008) 1.20
Effects of TGF-beta1 and triiodothyronine on cartilage maturation: in vitro analysis using long-term high-density micromass cultures of chick embryonic limb mesenchymal cells. J Orthop Res (2006) 1.20
Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res (2009) 1.20
Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med (2012) 1.19
Concise review: clinical translation of wound healing therapies based on mesenchymal stem cells. Stem Cells Transl Med (2011) 1.19
Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials (2012) 1.18
Current state of cartilage tissue engineering. Arthritis Res Ther (2003) 1.17
Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res Ther (2010) 1.16
Intervertebral disc cell response to dynamic compression is age and frequency dependent. J Orthop Res (2009) 1.16
In vivo response of polylactic acid-alginate scaffolds and bone marrow-derived cells for cartilage tissue engineering. Tissue Eng (2005) 1.14
Overexpression of an H+-PPase gene from Thellungiella halophila in cotton enhances salt tolerance and improves growth and photosynthetic performance. Plant Cell Physiol (2008) 1.14
Mesenchymal stem cells inhibit both endogenous and exogenous MMPs via secreted TIMPs. J Cell Physiol (2011) 1.14
Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol (2010) 1.14
Regulation of the chondrogenic phenotype in culture. Birth Defects Res C Embryo Today (2009) 1.13
Comparative gene expression profiling of normal and degenerative discs: analysis of a rabbit annular laceration model. Spine (Phila Pa 1976) (2002) 1.12
Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev (2010) 1.10
Evaluation of articular cartilage repair using biodegradable nanofibrous scaffolds in a swine model: a pilot study. J Tissue Eng Regen Med (2009) 1.10
Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res (2003) 1.10
Particle bioreactivity and wear-mediated osteolysis. J Arthroplasty (2004) 1.08
Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem (2002) 1.08
Concepts in gene therapy for cartilage repair. Injury (2008) 1.08
Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem (2009) 1.08
A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Mol Biotechnol (2003) 1.07
Stemming cartilage degeneration: adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthritis Rheum (2006) 1.07
In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng (2002) 1.07
Titanium particles suppress expression of osteoblastic phenotype in human mesenchymal stem cells. J Orthop Res (2002) 1.07
Adult mesenchymal stem cells: biological properties, characteristics, and applications in maxillofacial surgery. J Oral Maxillofac Surg (2007) 1.06
TGF-beta1 calcium signaling in osteoblasts. J Cell Biochem (2007) 1.06
Spatiotemporal protein distribution of TGF-betas, their receptors, and extracellular matrix molecules during embryonic tendon development. Dev Dyn (2008) 1.06
Repair of porcine articular cartilage defect with a biphasic osteochondral composite. J Orthop Res (2007) 1.05
Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation. J Cell Biochem (2009) 1.04
Biology of platelet-rich plasma and its clinical application in cartilage repair. Arthritis Res Ther (2014) 1.04
Tissue engineering with mesenchymal stem cells. IEEE Eng Med Biol Mag (2003) 1.03
Mold-shaped, nanofiber scaffold-based cartilage engineering using human mesenchymal stem cells and bioreactor. J Surg Res (2008) 1.03
Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol (2005) 1.03
A role for gamma/delta T cells in a mouse model of fracture healing. Arthritis Rheum (2009) 1.03
Transient differentiation of adult human bone marrow cells into neuron-like cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms. Stem Cells Dev (2004) 1.01
Repair of porcine articular cartilage defect with autologous chondrocyte transplantation. J Orthop Res (2005) 1.01
Morphogenesis and dysmorphogenesis of the appendicular skeleton. Birth Defects Res C Embryo Today (2003) 1.01
Enhancement of tenogenic differentiation of human adipose stem cells by tendon-derived extracellular matrix. Biomaterials (2013) 1.01
Application of visible light-based projection stereolithography for live cell-scaffold fabrication with designed architecture. Biomaterials (2012) 1.00
Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther (2010) 1.00
A prospective observational study of 363 cases operated with three different harmonic scalpels. Eur Arch Otorhinolaryngol (2009) 1.00